ARA-290

I-ARA-290 yi-peptide yokwenziwa eyenziwe 11 iiamino acids, Ithatyathwe kwimodeli yolwakhiwo olumacala-ntathu we-endogenous hormone erythropoietin (EPO).

 

 

SKU: 198804 Udidi:
Yabelana ngothando lwakho

I-ARA-290 yi-peptide yokwenziwa eyenziwe 11 iiamino acids, ephuma kwimodeli yolwakhiwo olunemigangatho emithathu yehomoni engapheliyo erythropoietin (EPO). Ilinganisa i-interface ebophelelayo ye-erythropoietin receptor β-co-receptor (βcR), ngokukhetha isebenze iprotheni ye-receptor yokulungisa. Okubaluleke ngakumbi, le ndlela yokuthintela ubungozi obunokunxulunyaniswa nezamkeli ze-EPO zemveli.

Kuqale kwaxelwa kwi 2008, ukuvela kwe-ARA-290 kubonisa utshintsho olucwangcisiweyo kuphando lwe-EPO ukusuka kunyango lwe-hematopoietic ukuya ekulungisweni kwezicubu ekujoliswe kuzo kunye. immunomodulation.
Ngoomatshini, ngokuzibophelela ngobudlelwane obuphezulu kwi-IRR, I-ARA-290 ngokukhethayo yenza ukuba kusebenze iindlela ezingundoqo zokubonisa umlambo, kuquka I-JAK2-STAT3 kwaye PI3K-Act, leyo ekugqibeleni imodareyitha iimpembelelo ezibalulekileyo ezifana NF-kB.

Ngaphaya koku, I-ARA-290 ibonisa imiphumo enamandla yokuchasana nokuvuvukala kunye ne-immunomodulatory, ikhuthaza ukulungiswa kwe-neural kunye nokunciphisa intlungu ye-neuropathic, ilawula imetabolism, kwaye ibonisa amandla onyango okunyanga i-fiber neuropathy encinci, Isifo sikaCharcot-Marie-Tooth, kunye ne-diabetes neuropathy.

Ulandelelwano

H-Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-OH

Inombolo yeCAS

1208243-50-8

Ifomula yeemolekyuli

I-C51H84N16O21

Ubunzima beMolekyuli

1257.3

Uphando lwe-ARA-290

1.Ukuphucula iAngiogenic Potential kunye neHoming Capacity ye Iiseli ze-Endothelial Progenitor ezijikelezayo:

  • Okokuqala, izifo ze-ischemic zibonakalisa ukuphazamiseka kwemithambo yegazi. Ngokuxhaphaka kokutyeba kunye nesifo seswekile, inani lezigulane ezichaphazelekayo liyaqhubeka nokunyuka. Ngenxa yoko, kubantu abanesifo esinzima se-vascular, ukunqunyulwa amalungu kuhlala kulukhetho lokuqala lonyango.
  • Kuphononongo olufanelekileyo, I-ARA-290 inikwe iimpuku nge i-ischemia yelungu elingapheliyo (CLI). Iziphumo zibonise ukuba i-ARA-290 yonyusa kakhulu ukwanda / ukufuduka kunye nokuchasana ne-apoptosis eyenziwe nge-hydrogen peroxide..
  • Ukongeza, inaliti enye ye-ARA-290 iphucule ukuhamba kwegazi kwelungu kunye noxinzelelo lwe-capillary.
    Ngokudibeneyo, ezi ziphumo zibonisa ukuba ukusebenzisa i-ARA-290 njenge-adjuvant kunokuphucula iimpawu ze-angiogenic zangaphakathi. I-Endothelial colony yenza iseli(IiECFCs) kunye ne-vivo yabo ukuya kwiindawo ze-ischemic, ngaloo ndlela ivuselela i-angiogenesis. Ngaloo ndlela, oku kubonelela ngendlela entsha yonyango yezifo ezingapheliyo ze-ischemic.

2.Ukuphucula ukukhutshwa kwe-insulin kunye nokuNyamezelwa kweGlucose kuHlobo 2 Izigulana zesifo seswekile:
Kwi-domain ye-metabolic, I-ARA-290 iphucula kakhulu ukunyamezela kweglucose kwiimpuku zesifo seswekile ngaphandle kokuchaphazela iigundane ezingenasifo seswekile.. Ngokuthe ngqo, ivuselela ukuphakama GSIS(I-Glucose-Stimulated Insulin Secretion) amanqanaba, ekugqibeleni kuphuculwe i-glucose oxidation kunye Adenosine triphosphate(ATP) imveliso. Ngale ndlela, ngempembelelo I-ATP-sensitive potassium channel(CAT) ukuvalwa komjelo, ekugqibeleni ichaphazela ukukhutshwa kwe-insulin.

3.I-Anti-inflammatory kunye ne-Neuroprotective Effects:
Ukuvavanya i-neuroinflammation, kulingo lonyango olubandakanya iimpuku zika Lewis nge uvavanyo lwe-autoimmune encephalomyelitis (EAE), ulawulo oluqhubekayo lwe-ARA-290 i-injection yanciphisa kakhulu ubunzima be-EAE kwiigundane. Ukuthi ngqo, olu nyango lunciphisa ukuqokelelwa kweeseli ezivuthayo kwintambo yomgogodla ye-EAE kwaye yacinezela ukwanda kunye nokubonakaliswa kwee-cytokines ezifana ne-interleukin., ithumba necrosis factor-α, kunye ne-inducible i-nitric oxide synthase kwi-EAE ibuzi intambo yomgogodla.

Ngaphaya koko, izifundo ze-in vitro zibonise ukuba i-ARA-290 iyanqanda Th1 kunye Th7 iseli i-polarization kwi-EAE lymphocytes. Kunye, olu lingelo lubonisa ukuba i-ARA-290 inexabiso lonyango elinokubakho kwi-multiple sclerosis.

4.Ukukhuthaza ukulungiswa kweNeural kunye nokunciphisa iintlungu zeNeuropathic:
Ngokucacileyo, I-ARA-290 inokuwela ngokuthe ngqo umqobo wegazi-ubuchopho, ukuyivumela ukuba isebenze ngokuthe ngqo Umqolo weengcambu ze ganglia kwaye microglia. Pha, icinezela ukukhutshwa okungaqhelekanga kwinkqubo yengqondo ephakathi, kunciphisa uvakalelo oluphakathi, kwaye imodareyitha ngenkuthalo izinto ze-neurotrophic ngelixa inciphisa ukudumba kwi-dorsal root ganglia ukulungisa inkqubo ye-nervous central..

5.Ukuphucula ukulungiswa kweTissue kunye neSakhono sokuHlaziya:
Ekugqibeleni, I-ARA-290 isebenza kwiiseli zokhuselo lomzimba ezibonisa i-IRR, ekhuthaza ngamandla i-polarization yabo kwi-pro-inflammatory M1 phenotype ukuya kwi-anti-inflammatory kunye ne-pro-repair M2 phenotype. Nje ngeziphumo, icinezela iimpendulo ezivuthayo ezigqithisileyo ngelixa ivuselela ukukhuselwa kwezinto ezininzi zokukhula, ukucoca iiseli ze-apoptotic, kunye nokwenza imithambo yegazi emitsha. Ekugqibeleni, oku kuphucula ukunyaniseka kwesakhiwo kunye neempawu zemishini yezicubu ezilungisiweyo.

I-COA

HPLC

NKSK

(1) Izembe, G.; Garrigue, P.; Bennis, Y.; Stalin, J.; Intliziyo, A.; ICerami, A.; Iibrines, M.; Blot-Chabaud, M.; Sabatier, F.; UDignat-George, F.; okqhubekayo. ARA290, i-Specific Agonist ye-Erythropoietin/CD131 Heteroreceptor, Ukuphucula i-Curculating Endothelial Progenitors 'Angiogenic Potential kunye neHoming Ability. Umothuko 2016, 46 (4), 390-397. DOI: 10.1097/CS.0000000000000606.

(2) Muller, C.; Yassin, K.; Li, L.-S.; Igqabi lesundu, M.; Efendic, S.; Isebe laseNtabeni, EMVA.; ICerami, A.; Iibrines, M.; Östenson, C.-G. I-ARA290 iphucula ukukhutshwa kwe-insulin kunye nokunyamezelwa kwe-Glucose kuHlobo 2 Iimpuku ze-Diabetic Goto-Kakizaki. Iyeza leMolekyuli 2015, 21 (1), 969-978. DOI: 10.2119/molmed.2015.00267.

(3) Chen, H.; IsiLuo, B.; Yiyiphi, X.; Xiong, J.; Liu, Z.; Jiang, M.; Shi, R.; Yan, C.; Wu, Y.; Zhang, Z. Iziphumo zonyango lwe-nonerythropoietic erythropoietin analog ARA290 kuvavanyo lwerat ye-autoimmune encephalomyelitis. Ijenali yeNeuroimmunology 2014, 268 (1-2), 64-70. DOI: 10.1016/j.jneuroim.2014.01.006.

(4) deVries, M. R.; de Jong, R. C. M.; Peters, H. A. B.; Ukunqunqa, J. F.; IiGoumans, M. J.; Iquax, P. H. A. I-Vegfr2 blockade kwi-murine vein graft iphumela ekunciphiseni ukopha kwe-intraplaque kunye nezilonda ezizinzileyo ze-atherosclerotic.. Atherosclerosis 2014, 235 (2), e161-e162. DOI: 10.1016/j.atherosclerosis.2014.05.463.

(5) Bastiaansen, T.; Ikhaphu, J.; I-Weasel, A.; eBoer, H.; imihlaba, S.; Aref, Z.; de Jong, R.; Peters, E.; deVries, M.; van Oeren-Rietdijk, A.; okqhubekayo. TLR4 Isincedisi Imolekyuli RP105 (CD180) Ilawula i-Arteriogenesis kunye ne-Angiogenesis. Ijenali yaseYurophu yeVascular kunye ne-Endovascular Surgery 2014, 47 (6), 695-696. DOI: 10.1016/j.ejvs.2014.03.033.

(6) Ndayichola, M.; Thiemermann, C.; ICerami, A.; Iibrines, M. Ukuphehla iswitshi yemolekyuli yokhuseleko lwangaphakathi kunye nokulungiswa kwezicubu: Iziphumo ezihlala ixesha elide ze-peptide encinci ye-non-erythropoietic eyenziwe nge-erythropoietin. I-Pharmacology & Unyango 2015, 151, 32-40. DOI: 10.1016/j.pharmthera.2015.02.005.

iinkcukacha

12mg

Ekhaya Khangela Whatsapp Iinkonzo Imveliso